Zepbound Returns to the Prescription Drug Formulary on October 1, 2026
Zepbound will return to the NRECA Medical Plan’s prescription drug formulary as an additional preferred GLP-1 option for use with weight loss beginning October 1, 2026. This update will give your plan participants and their providers more flexibility to choose[…]
